1.88 +0.01 (0.53%)
NSPH
| Trade NSPH now with |
Stock Details
Last Trade:1.88 Change:+0.01 (0.53%) Prev Close:1.87 Open: 1.88 Days Range:1.82 – 1.91 52 Week Range: 0.89 - 3.89 Volume:138282 P/E: N/AEPS:-1.03
View AllRecent Alerts 02/09/12
Recent Alert on 12/27/11 at 2:28pm
Nanosphere (NSPH) Shares Surge 16% Upon FDA Clearance of Gram-Positive Blood Culture Test
Nanosphere (NSPH) Shares Surge 16% Upon FDA Clearance of Gram-Positive Blood Culture Test
Nanosphere (Nasdaq: NSPH) shares have just surged about 16 percent following mid-day news of FDA clearance for its Gram-Positive blood culture test for staphylococcus. The stock last traded at $1.46.
Recent Alert on 12/27/11 at 2:26pm
Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S
Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S
Recent Alert on 12/27/11 at 2:26pm
Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S
Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S
Recent Alert on 12/23/11 at 10:32am
Notable Analyst Rating Changes 12/23: (GEO) (TLM) Upgraded; (CHCO) (AM) (RAM) Downgraded
Notable Analyst Rating Changes 12/23: (GEO) (TLM) Upgraded; (CHCO) (AM) (RAM) Downgraded
Recent Alert on 12/23/11 at 9:26am
Roth Capital Starts Nanosphere (NSPH) at Neutral, $2 Price Target
Roth Capital Starts Nanosphere (NSPH) at Neutral, $2 Price Target
View AllRecent Press Releases
Press Release on 02/06/12 at 4:52pm
Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16
Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/25/11 at 4:42am
Healthcare Sector's Insider Buy And Sell SEC Filings From Last Week
Healthcare Sector's Insider Buy And Sell SEC Filings From Last Week
Blog Posts on 09/29/11 at 8:30am
Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners
Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners


